Scan: When will Oura Health Oy officially announce an IPO? — Before Oct 1, 2026

date	predicted	market price	confidence
2026-09-08	76%	70%	58%
2026-08-31	23%	41%	54%
2026-08-24	19%	16%	56%

1. Planner Fable 5.1 · Fermi decomposition + tool plan

Tools chosen: kalshi_direct kalshi_related polymarket_related article_search claude_news gdelt_news wikipedia

Sub-questions (Fermi decomposition)

What is the current Kalshi YES price and volume on KXIPOOURA-26OCT01, and how has it trended?
Has Oura CEO Tom Hale or its board made any public statements in 2025-2026 about IPO timing (e.g., 'not before 2027', 'considering 2026')?
Are there credible reports (Bloomberg, Reuters, FT, TechCrunch) of Oura hiring banks, confidentially filing an S-1, or conducting IPO preparations?
How much runway does Oura have from its 2025 fundraising round (~$900M at ~$11B valuation), reducing near-term pressure to go public?
What is the state of the 2026 tech IPO window (recent consumer hardware/health-tech IPOs, market volatility) that would affect Oura's decision?
What counts as 'officially announce/confirm an IPO' under Kalshi's resolution — public S-1 filing, press release, or CEO confirmation of plans — and how does that affect the effective threshold?

Planner reasoning

Oura is a private Finnish wearables company that raised a large round in late 2025 at ~$11B valuation; the question is whether it will officially confirm an IPO before Oct 1, 2026. Key drivers are CEO/board public statements on IPO timing, any confidential S-1 filing reports, the 2026 IPO window health, and how Kalshi defines 'confirms an IPO' (public filing vs. announcement). The Kalshi price is the primary anchor; news search for CEO Tom Hale's statements and filing rumors will refine it.

2. Research Parallel tool calls

tool	status	time	items	summary
kalshi_direct	OK	0.2s	1	## This Market's Kalshi Data Before Oct 1, 2026 (KXIPOOURA-26OCT01) - Current price (probability): 60.00% - 7-day price change: -10.00% - 30-day price change: +29.00% - Average daily volume: 429 contracts - Price range: 9.00% - 76.00% - Data points: 35 days
kalshi_related	OK	2.9s	2	2 related markets / summaries. series KXIPOOURA: 0 markets (skipped 6 no-signal) \| keyword 'Oura IPO': ok \| keyword 'IPO announce': ok
polymarket_related	OK	2.9s	0	Scanned 100 active Polymarket markets, kept 0 matches. keyword 'Oura': 0 markets \| keyword 'Oura IPO': 0 markets
article_search	OK	3.3s	29	Fetched 29 unique articles across 4 queries (lookback=180d). 'Oura IPO plans': 10 articles \| 'Oura Health Tom Hale IPO timing': 10 articles \| 'Oura confidential S-1 filing': 10 articles \| 'Oura funding round valuation': 10 articles
claude_news	OK	17.7s	14	## Key Findings on Oura Health IPO Timing - Confidential filing (May 21, 2026): Oura, the maker of the health and wellness tracking smart ring, has confidentially filed for an IPO with the SEC. Oura did not specify the timeline for an IPO, saying it would take place after the SEC completes i
gdelt_news	OK	209.5s	20	GDELT: 20 articles across 3 queries (lookback=90d). 'Oura IPO': error GDELT rate-limited after retries (429) \| 'Oura Health public offering': 10 hits \| 'Oura ring listing': 10 hits
wikipedia	OK	3.0s	2	Fetched 2 Wikipedia entries (0 missing pages).

3. Evidence Brief Sonnet 5 · 6271 chars

# Current state Oura has already progressed from confidential IPO filing (May 21, 2026, publicly disclosed by the company) to a **public S-1 filing with the SEC on Sept 3, 2026**, listing under Nasdaq ticker "OURA," with bankers (Goldman Sachs, Morgan Stanley, JPMorgan, later Allen & Co./Jefferies) already engaged. Bloomberg (Aug 24, 2026) reported Oura was targeting a listing "as soon as September" 2026 at a valuation >$16B. As of the S-1, no final price, date, or share count is set — the distinction between "officially announcing/confirming an IPO" (arguably already satisfied) versus "completing/pricing the IPO" (not yet confirmed) is the core ambiguity for this market. # Timeline of key events - 2025-09-28 (confirmed): CEO Tom Hale (TechCrunch) says Oura "could go public," calls it "an option," no commitment. - 2025-10 (confirmed): Oura closes ~$900M Series E at ~$11B valuation. - 2025-11-11 (confirmed): Hale tells CNBC "no news on an IPO," despite ~$2B 2026 sales guidance. - 2026-05-21 (confirmed): Oura confidentially files draft IPO prospectus with SEC (company-announced); no timeline given. - 2026-05-28 (confirmed): Oura launches smallest smart ring; reiterates confidential IPO filing, still no timeline. - 2026-08-24 (reported): Bloomberg — Oura and backers seeking up to $3B raise, IPO "as soon as September," valuation >$16B. - 2026-08-27 (reported): Proactiveinvestors — prediction-market traders betting Oura lists above $16B target (signals market expects imminent listing). - 2026-09-03 (confirmed): Oura files public Form S-1 with SEC, Nasdaq ticker "OURA"; revenue $1,214.5M (9 mo. ended June 30, 2026, +74% YoY), $60.8M net income; no date/price/share count set. - 2026-09-04/05 (confirmed): Multiple outlets (Fool, ETRetail) cover S-1 financial disclosures; IPO pricing still pending. # Event Will Oura Health Oy officially announce an IPO before Oct 1, 2026? (KXIPOOURA-26OCT01) # Outcomes to forecast Yes / No # Kalshi market anchor **Current YES price: 60%** (as of data snapshot). 7-day change: -10pp; 30-day change: +29pp. Price range over 35 days: 9%–76%. Avg daily volume: 429 contracts — moderate liquidity, meaningful volatility suggesting active repricing around IPO news flow. # Sub-question answers 1. **Kalshi price/trend** — 60% YES, down 10pp in 7 days but up 29pp over 30 days; range 9-76% shows the market has swung sharply as IPO news emerged (kalshi_direct). 2. **CEO/board statements** — Hale: Sept 2025 "could go public... an option"; Nov 2025 "no news on an IPO"; no explicit 2027/2026 timing commitment reported (claude_news, CNBC). 3. **Bank hiring/S-1 filings** — Confirmed: confidential draft filed May 21, 2026; public S-1 filed Sept 3, 2026 (Nasdaq "OURA"); underwriters Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Co., Jefferies (claude_news, CNBC, Yahoo Finance). 4. **2025 fundraising runway** — $900M raised Oct 2025 at ~$11B valuation reduced near-term cash pressure, but company proceeded with IPO anyway within ~8 months, suggesting strategic (not distress-driven) timing (wikipedia/article_search). 5. **2026 IPO window** — Very active: SpaceX (~$2T target), Anthropic, OpenAI all filing/IPOing mid-2026; BofA flagged "end of bull run" risk from mega-IPO capital absorption, which could pressure smaller offerings like Oura's timing (CNBC). 6. **Resolution threshold ambiguity** — No official Kalshi rules text provided beyond "confirms an IPO." Confidential filing (May) + public S-1 (Sept 3) arguably already constitute "confirming an IPO," but if the bar requires actual pricing/listing, that remains unresolved as of Sept 5, 2026 reporting. # Key facts (high-confidence, factual) 1. [CNBC] Oura confidentially filed IPO draft with SEC, May 21, 2026. 2. [claude_news/multiple] Oura publicly filed Form S-1, Sept 3, 2026, ticker "OURA" on Nasdaq. 3. [Bloomberg via claude_news] Targeting up to $3B raise, listing "as soon as September" 2026, valuation >$16B. 4. [claude_news] 9-month revenue to June 30, 2026: $1,214.5M (+74% YoY), net income $60.8M. 5. [Wikipedia] Oura raised $900M Series E at ~$11B valuation, Oct 2025. # Cross-market signals - Kalshi related: Similar "officially announce IPO" markets (Bloomberg 18%, Airtable 9%, Perplexity 56%) show these markets typically price well below certainty even amid rumors — Oura's 60% is comparatively high, reflecting concrete S-1 filing. - Polymarket: No matching markets found. - Other: proactiveinvestors reports prediction-market traders already betting Oura lists above $16B — implies market consensus expects the IPO to proceed, not just be "announced." # Analyst opinions and speculation - BofA (May 2026): Mega-IPOs (SpaceX, Anthropic) could "squeeze oxygen" from capital pools, risking delay for smaller floats like Oura. - Multiple outlets frame Oura as part of a 2026 "IPO wave," alongside SpaceX/Anthropic/OpenAI, suggesting favorable window momentum despite bubble concerns. # Directional lean per outcome - **Yes**: Confidential filing (May) + public S-1 (Sept 3) already largely satisfy "officially announce/confirm an IPO"; Bloomberg-reported "as soon as September" target listing directly precedes Oct 1 close; heavy underwriter commitment signals high follow-through likelihood. - **No**: No IPO date/pricing set as of Sept 5 reporting; congested 2026 IPO calendar (SpaceX, Anthropic, OpenAI) could delay Oura past Oct 1; Kalshi's own 60% (down from recent highs) suggests some doubt about completion timing; ambiguity in resolution criteria could favor stricter "completed listing" interpretation. # Gaps / unknowns - Whether Kalshi resolution requires only "announcement/confirmation" (already arguably met) vs. actual pricing/trading start (not yet confirmed as of data cutoff). - No confirmed IPO pricing date or roadshow schedule found in research. - Data snapshot for Kalshi price may predate the Sept 3 S-1 filing, understating current market probability. # Calibration anchors - Kalshi current YES price: 60% (anchor), with strong 30-day uptrend (+29pp) into filing news. - Precedent: Anthropic (94% "IPO first" market) and SpaceX moved from confidential filing to actual public listing within 1-3 months in 2026, supporting plausibility of Oura completing by Oct 1 if "September listing" target holds.

4. Forecasters Fable 5.1 + GPT-5.6 Sol · in parallel

claude-fable-5-1

66% conf

Yes	89%
No	11%

The brief reports (multi-source, marked confirmed) that Oura publicly filed a Form S-1 on Sept 3, 2026 with Nasdaq ticker 'OURA' and a full underwriter syndicate, following its company-announced confidential filing in May. Kalshi 'officially announce IPO' markets typically resolve YES on a public S-1 filing or explicit company announcement, so the Sept 3 filing very likely already satisfies the bar; the Kalshi anchor of 60% appears to be a stale snapshot predating the S-1 (the brief itself flags this), which justifies moving well above it. Even under a stricter 'pricing/listing' reading, Bloomberg's 'as soon as September' target and precedent of 1-3 month filing-to-listing timelines give a meaningful chance of completion before Oct 1. Residual NO probability reflects the possibility the S-1 report is inaccurate or that resolution requires an actual listing that slips past Oct 1 amid a crowded IPO calendar.

gpt-5.6-sol

72% conf

Yes	84%
No	16%

The 60% Kalshi YES price is the anchor, but Oura’s company-disclosed confidential filing and especially its Sept. 3 public S-1 under ticker OURA provide stronger evidence than rumors or preliminary CEO comments. Named underwriters, strong disclosed financials, and Bloomberg’s report of a listing as soon as September further favor YES despite Oura’s ample fundraising runway and competition from other major IPOs. I move materially above the market because a public S-1 ordinarily constitutes an official IPO announcement and may mean the event is already satisfied. The remaining NO probability reflects the missing resolution rules and the possibility that adjudication requires pricing or listing before Oct. 1, neither of which was confirmed in the brief.

5. Devil's Advocate Sonnet 5 · red-team critique

Both forecasts converge tightly (0.84–0.89 YES) despite the brief explicitly flagging the resolution-criteria ambiguity as "the core ambiguity for this market" — neither meaningfully wrestles with the scenario where Kalshi requires actual pricing/completion, which the brief's cross-market comparisons (Bloomberg 18%, Airtable 9%) suggest is the more common resolution standard for "officially announce IPO" markets, not mere S-1 filing.

Neither forecaster explains why the Kalshi price sits at 60% and fell 10pp in the last 7 days (which spans the Sept 3 S-1 filing) rather than spiking — if S-1 filing obviously satisfied "announce," the market should have jumped to near-certainty, not stayed flat/declined; this is evidence against the "stale snapshot" dismissal both forecasters lean on.

The brief's own cross-market comparisons are underused: Perplexity at 56% and Bloomberg at 18% for similar "announce IPO" markets after credible rumors/filings suggest these markets are calibrated well below 90% even with concrete filings — both forecasts jump to ~85-90% without reconciling why Oura should be a major outlier from this reference class.

Both forecasts dismiss the BofA "mega-IPO squeeze" and crowded 2026 calendar risk (SpaceX ~$2T, Anthropic, OpenAI) too lightly, treating it as a minor residual risk rather than weighing that congestion could specifically push Oura's listing (if that's the bar) past Oct 1 — this is a plausible tail scenario neither quantifies.

Neither forecast considers the scenario where Kalshi's own market behavior (down 10pp in the 7 days including the S-1 filing) is itself the strongest available signal about how resolution will actually be interpreted — treating it as "stale" without evidence is an assumption, not a fact, and deserves more hedging in the final probability.

Both forecasts converge near 84-89% with only modest confidence stated (0.66, 0.72), creating a mismatch: if they're this confident in the probability estimate, confidence should be higher; if resolution ambiguity is truly "the core" issue as the brief states, the probability itself should show more spread/uncertainty (e.g., closer to 65-75%) rather than clustering near 85-90%.

6. Aggregator Fable 5.1 · final calibrated forecast

75% (69% confidence)

Yes: 75% No: 25%

Oura's company-disclosed confidential filing (May 21) and public S-1 with Nasdaq ticker 'OURA' (Sept 3) would clearly satisfy an 'officially announce/confirm an IPO' standard, which is the most natural reading of the market title and would put YES near-certain. However, the critique is right that the Kalshi price sitting at 60% and falling 10pp over a window that plausibly includes the S-1 filing is evidence the market may be treating the bar as actual pricing/listing before Oct 1 — under that reading, a September listing is targeted but unconfirmed (no date, price, or roadshow), and the ~15-day post-S-1 waiting period plus a congested IPO calendar make completion by Sept 30 roughly a coin flip. Weighting the two interpretations (roughly 55/45) yields ~0.75, above the market anchor because the S-1 is strong hard evidence and the snapshot may be stale, but below both forecasters because they underweighted the resolution-criteria ambiguity the brief flags as central.

Pipeline Timing

Total pipeline time: 314.6s

Per-tool research timings shown in the Research section above.